EXPAREL is a Infiltration Injection, Suspension, Liposomal in the Human Prescription Drug category. It is labeled and distributed by Pacira Pharmaceuticals Inc.. The primary component is Bupivacaine.
Product ID | 65250-266_23030401-c18b-4366-b87d-addbe252269b |
NDC | 65250-266 |
Product Type | Human Prescription Drug |
Proprietary Name | EXPAREL |
Generic Name | Bupivacaine |
Dosage Form | Injection, Suspension, Liposomal |
Route of Administration | INFILTRATION |
Marketing Start Date | 2012-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022496 |
Labeler Name | Pacira Pharmaceuticals Inc. |
Substance Name | BUPIVACAINE |
Active Ingredient Strength | 13 mg/mL |
Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2016-09-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-09-28 |
Marketing Category | NDA |
Application Number | NDA022496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2012-01-01 |
Marketing Category | NDA |
Application Number | NDA022496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-03-31 |
Ingredient | Strength |
---|---|
BUPIVACAINE | 13.3 mg/mL |
SPL SET ID: | bb5a9e59-0f51-11df-8a39-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
65250-133 | EXPAREL | bupivacaine |
65250-266 | EXPAREL | bupivacaine |
49396-6601 | POSIMIR | Bupivacaine |
51715-660 | POSIMIR | bupivacaine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXPAREL 77464815 4074454 Live/Registered |
Pacira Pharmaceuticals, Inc. 2008-05-02 |